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The first two cats with diabetes mellitus and acromegaly were described in the mid 
70ths of the last century. During the following 30 years further cases were only 
published sporadically and acromegaly was considered to be a rare disease. The 
rareness started to be questioned in 2007 when blood samples of diabetic cats were 
screened in the UK for possible presence of acromegaly by measuring IGF-1 levels. 
They were found to be increased (> 1000 ng/dl) in 32% of diabetic cats. Further 
work-up was possible in 18 of those cats and acromegaly was confirmed in 17 of 
them. Another, larger screening project was undertaken by the same research group 
and found increased IGF-1 in 27.3% of diabetic cats. These combined results 
suggest that the prevalence of acromegaly is high, at least in the UK (Niessen et al 
2007, Niessen et al 2013). However, when similar studies were performed in 
Switzerland and the Netherlands, prevalence of high IGF-1 levels was substantially 
lower (17.8%). Most importantly, no pituitary mass was found in the majority of cats 
with high IGF-1 levels in which CT imaging was performed in the Suisse-Dutch study 
(Schaefer et al 2013).  
The speakers, involved in the UK and Suisse-Dutch studies respectively, will give 
their (at times opposing) views and discuss the following topics with the delegates:  
- What is the estimated prevalence in the overall population of diabetic cats and 
in cats which are difficult to regulate?  
- What does a high IGF-1 level mean, resp. what are causes for false positive 
results? Diagnostic tests may also be false negative, is this also true for IGF-
1? 
- Is it good medicine to routinely screen every diabetic cat for acromegaly? 
- Should the assumption that at least 80% of diabetic cats suffer type 2 diabetes 
be discarded? 
- What are the most typical abnormalities in cats with acromegaly? Are they 
always present? 
- Can acromegaly be overlooked during physical examination? 
- Are all acromegalic cats insulin-resistant and how much insulin do they need? 
- Surgery, radiation or medical treatment: which is best?  
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